Zepbound® (tirzepatide) is a medication developed by Eli Lilly and Company. It is primarily used to treat weight loss in patients. Zepbound® is an injectable drug that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These receptors are involved in the regulation of blood sugar levels and appetite.
What is Zepbound®?
